Francesca Giovannelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Francesca Giovannelli has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Berni
Division of Cardiology, Sant’Andrea Hospital, 00189 Rome, Italy; Department of Clinical and Molecular Medicine, Sapienza University of Rome, 00189 Rome, Italy
5 shared publications - Antonella Tommasino
Division of Cardiology, Sant’Andrea Hospital, 00189 Rome, Italy
5 shared publications - Emanuele Barbato
Department of Clinical and Molecular Medicine, Sapienza University of Rome, 00185 Roma, Italy
5 shared publications - Matteo Casenghi
Department of Cardiology Sant'Andrea Hospital Rome Italy
5 shared publications - Stefano Rigattieri
Department of Cardiology Sant'Andrea Hospital Rome Italy
5 shared publications - Marco Redivo
Cardiology Division, Sant’Andrea University Hospital, 00189 Rome, Italy
3 shared publications
Latest Publications
- Open Access
- 17 April 2025
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 26 (4) , 26712
Management of Coronary Vulnerable Plaques: A Focus on Preventive Percutaneous Coronary Intervention
Vulnerable or high-risk coronary plaques are usually referred to as angiographically mild to moderate lesions characterized by a large plaque burden, positive vessel remodeling, thin fibrous cap, and large necrotic/lipid core. According to several pathology studies, these plaques represent the substrate of coronary thrombosis in about two-thirds of cases; therefore, there has been increasing interest in detecting and treating vulnerable plaques (VPs). Nowadays, VP detection is possible through noninvasive and invasive imaging techniques, such as coronary computed tomography, magnetic resonance imaging, intravascular ultrasound, optical coherence tomography, and near-infrared spectroscopy. Since VPs were shown to be associated with cardiovascular events in observational studies, pharmacological and non-pharmacological strategies have been investigated to achieve a regression and/or a passivation of these plaques. In addition to pharmacological therapies, mainly focused on lipid-lowering agents, there has been a recent growing interest in interventional therapies, including coronary scaffolds, stents, and drug-coated balloons. This led to the concept of preventive percutaneous coronary intervention, which, unlike the treatment of culprit lesions in acute coronary syndromes or of ischemia-inducing stenoses, as recommended by guidelines, implies the treatment of angiographically and functionally non-significant lesions based on one or more high-risk plaque characteristics as identified by noninvasive or intracoronary imaging. This article provides an updated review of key concepts in defining and detecting VPs; their prognostic value and available pharmacological and interventional management evidence will also be discussed.
- 17 April 2025
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 26 (4) , 26712
Open AccessManagement of Coronary Vulnerable Plaques: A Focus on Preventive Percutaneous Coronary Intervention
Vulnerable or high-risk coronary plaques are usually referred to as angiographically mild to moderate lesions characterized by a large plaque burden, positive vessel remodeling, thin fibrous cap, and large necrotic/lipid core. According to several pathology studies, these plaques represent the substrate of coronary thrombosis in about two-thirds of cases; therefore, there has been increasing interest in detecting and treating vulnerable plaques (VPs). Nowadays, VP detection is possible through noninvasive and invasive imaging techniques, such as coronary computed tomography, magnetic resonance imaging, intravascular ultrasound, optical coherence tomography, and near-infrared spectroscopy. Since VPs were shown to be associated with cardiovascular events in observational studies, pharmacological and non-pharmacological strategies have been investigated to achieve a regression and/or a passivation of these plaques. In addition to pharmacological therapies, mainly focused on lipid-lowering agents, there has been a recent growing interest in interventional therapies, including coronary scaffolds, stents, and drug-coated balloons. This led to the concept of preventive percutaneous coronary intervention, which, unlike the treatment of culprit lesions in acute coronary syndromes or of ischemia-inducing stenoses, as recommended by guidelines, implies the treatment of angiographically and functionally non-significant lesions based on one or more high-risk plaque characteristics as identified by noninvasive or intracoronary imaging. This article provides an updated review of key concepts in defining and detecting VPs; their prognostic value and available pharmacological and interventional management evidence will also be discussed.
- Open Access
- 13 January 2025
- Published by IMR Press in The Heart Surgery Forum
- Vol. 28 (1) , E107-E119
The New Era of Coronary Angioplasty: How Cutting-Edge Technologies are Redefining Complex Interventions
Interventional cardiologists have recently become increasingly entrusted with the treatment of frail patients with complex coronary anatomy. Additionally, calcified lesions (CLs) have become more common due to the continued increase in the older population worldwide, increasing the need for simpler treatment options for such complex lesions. Hence, numerous debulking tools have recently been developed to overcome the difficulties associated with the angioplasty of CLs and to optimize stent positioning and delivery. In addition, bifurcation lesions (BLs) have always been more challenging than other lesions, requiring more specialized tools and complex strategies. Finally, intravascular imaging (IVI) is becoming increasingly important in assessing the complexity of lesions and optimizing procedural approaches. This article provides an overview of how complex procedures should be approached, from the choice of access and catheter to the use of specialized devices developed to assist cardiac catheterization laboratory operators in these complex scenarios.
- 13 January 2025
- Published by IMR Press in The Heart Surgery Forum
- Vol. 28 (1) , E107-E119
Open AccessThe New Era of Coronary Angioplasty: How Cutting-Edge Technologies are Redefining Complex Interventions
Interventional cardiologists have recently become increasingly entrusted with the treatment of frail patients with complex coronary anatomy. Additionally, calcified lesions (CLs) have become more common due to the continued increase in the older population worldwide, increasing the need for simpler treatment options for such complex lesions. Hence, numerous debulking tools have recently been developed to overcome the difficulties associated with the angioplasty of CLs and to optimize stent positioning and delivery. In addition, bifurcation lesions (BLs) have always been more challenging than other lesions, requiring more specialized tools and complex strategies. Finally, intravascular imaging (IVI) is becoming increasingly important in assessing the complexity of lesions and optimizing procedural approaches. This article provides an overview of how complex procedures should be approached, from the choice of access and catheter to the use of specialized devices developed to assist cardiac catheterization laboratory operators in these complex scenarios.
- Open Access
- 23 October 2024
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 11 (11) , 338
Comprehensive Risk Assessment of LAD Disease Progression in CCTA: The CLAP Score Study
Background: a wider left main bifurcation angle (LMBA) has been linked to severe plaque development in the proximal left anterior descending artery (LAD). This study aimed to identify predictors of severe proximal LAD stenosis and major adverse cardiovascular events (MACE) using coronary computed tomography angiography (CCTA). Methods: from an initial cohort of 650 consecutive patients, we analyzed 499 patients who met the inclusion criteria after exclusions. Plaque morphology and characteristics were assessed by CCTA, and MACE occurrences were recorded at follow-up. A predictive score for LAD disease progression (CLAP score) was developed and validated. Results: severe proximal LAD stenosis was detected in 32% (160/499) of patients by CCTA. MACE occurred in 12.5% of patients at follow-up. Significant predictors of MACE were LMBA > 80° (HR: 4.47; 95% CI: 3.80–6.70; p < 0.001), diabetes (HR: 2.94; 95% CI: 1.54–4.63; p = 0.031), chronic kidney disease (HR: 1.71; 95% CI: 1.31–6.72; p = 0.041), high-risk plaques (HR: 2.30; 95% CI: 1.45–3.64; p < 0.01), obstructive CAD (HR: 2.50; 95% CI: 1.50 to 4.10, p = 0.01), and calcium score (CAC) (HR: 1.05; 95% CI: 1.02–1.08, p = 0.004). The CLAP score demonstrated good discriminatory power in both the development (AUC 0.91; 95% CI: 0.86–0.96) and validation cohorts (AUC 0.85; 95% CI: 0.79–0.91); Conclusions: LMBA > 80°, diabetes, chronic kidney disease, obstructive CAD, CAC score >180 and high-risk plaques were significant predictors of MACE in CCTA patients. The CLAP score effectively predicted LAD disease progression, aiding in risk stratification and optimization of intervention strategies for suspected coronary artery disease.
- 23 October 2024
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 11 (11) , 338
Open AccessComprehensive Risk Assessment of LAD Disease Progression in CCTA: The CLAP Score Study
Background: a wider left main bifurcation angle (LMBA) has been linked to severe plaque development in the proximal left anterior descending artery (LAD). This study aimed to identify predictors of severe proximal LAD stenosis and major adverse cardiovascular events (MACE) using coronary computed tomography angiography (CCTA). Methods: from an initial cohort of 650 consecutive patients, we analyzed 499 patients who met the inclusion criteria after exclusions. Plaque morphology and characteristics were assessed by CCTA, and MACE occurrences were recorded at follow-up. A predictive score for LAD disease progression (CLAP score) was developed and validated. Results: severe proximal LAD stenosis was detected in 32% (160/499) of patients by CCTA. MACE occurred in 12.5% of patients at follow-up. Significant predictors of MACE were LMBA > 80° (HR: 4.47; 95% CI: 3.80–6.70; p < 0.001), diabetes (HR: 2.94; 95% CI: 1.54–4.63; p = 0.031), chronic kidney disease (HR: 1.71; 95% CI: 1.31–6.72; p = 0.041), high-risk plaques (HR: 2.30; 95% CI: 1.45–3.64; p < 0.01), obstructive CAD (HR: 2.50; 95% CI: 1.50 to 4.10, p = 0.01), and calcium score (CAC) (HR: 1.05; 95% CI: 1.02–1.08, p = 0.004). The CLAP score demonstrated good discriminatory power in both the development (AUC 0.91; 95% CI: 0.86–0.96) and validation cohorts (AUC 0.85; 95% CI: 0.79–0.91); Conclusions: LMBA > 80°, diabetes, chronic kidney disease, obstructive CAD, CAC score >180 and high-risk plaques were significant predictors of MACE in CCTA patients. The CLAP score effectively predicted LAD disease progression, aiding in risk stratification and optimization of intervention strategies for suspected coronary artery disease.
- Open Access
- 18 April 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (8) , 2367
Acute Kidney Injury in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: The Role of Vascular Access Site
Background: in patients undergoing percutaneous coronary interventions (PCI), radial access should be favoured over femoral access as it reduces the risk of vascular complications and bleeding. Furthermore, a preventive role of radial access in the occurrence of acute kidney injury (AKI), mainly mediated by the reduction of bleeding and cholesterol crystal embolization into renal circulation, has been investigated in several studies, yielding conflicting results. Methods: we designed a retrospective study to appraise the effect of the use of a vascular access site on the occurrence of AKI in a cohort of 633 patients with acute myocardial infarction treated by PCI at our centre from 2018 to 2020. Results: after propensity score adjustment, radial access was associated with a reduced, albeit statistically not significant, incidence of AKI (14.7% vs. 21.0%; p = 0.06) and major bleeding (12.5% vs. 18.7%; p = 0.04) as compared to femoral access. At multivariate analysis, femoral access was an independent predictor of AKI, together with in-hospital occurrence of BARC 3–5 bleeding, Killip class >1 at presentation, female gender, baseline eGFR <60 mL/min, and baseline haemoglobin <12 g/dL. Conclusions: although limited by the observational design, our study supports the hypothesis that radial access may exert a protective role on the occurrence of AKI in patients with acute myocardial infarction undergoing PCI.
- 18 April 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (8) , 2367
Open AccessAcute Kidney Injury in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: The Role of Vascular Access Site
Background: in patients undergoing percutaneous coronary interventions (PCI), radial access should be favoured over femoral access as it reduces the risk of vascular complications and bleeding. Furthermore, a preventive role of radial access in the occurrence of acute kidney injury (AKI), mainly mediated by the reduction of bleeding and cholesterol crystal embolization into renal circulation, has been investigated in several studies, yielding conflicting results. Methods: we designed a retrospective study to appraise the effect of the use of a vascular access site on the occurrence of AKI in a cohort of 633 patients with acute myocardial infarction treated by PCI at our centre from 2018 to 2020. Results: after propensity score adjustment, radial access was associated with a reduced, albeit statistically not significant, incidence of AKI (14.7% vs. 21.0%; p = 0.06) and major bleeding (12.5% vs. 18.7%; p = 0.04) as compared to femoral access. At multivariate analysis, femoral access was an independent predictor of AKI, together with in-hospital occurrence of BARC 3–5 bleeding, Killip class >1 at presentation, female gender, baseline eGFR <60 mL/min, and baseline haemoglobin <12 g/dL. Conclusions: although limited by the observational design, our study supports the hypothesis that radial access may exert a protective role on the occurrence of AKI in patients with acute myocardial infarction undergoing PCI.
- Open Access
- 1 January 2024
- Published by XMLink in Korean Circulation Journal
- Vol. 54 (3) , 160-163
Coronary Cameral Fistula With Giant Aneurysm
Tommasino A, et al. Korean Circ J. 2024 Mar;54(3):160-163. https://doi.org/10.4070/kcj.2023.0245
- 1 January 2024
- Published by XMLink in Korean Circulation Journal
- Vol. 54 (3) , 160-163
Open AccessCoronary Cameral Fistula With Giant Aneurysm
Tommasino A, et al. Korean Circ J. 2024 Mar;54(3):160-163. https://doi.org/10.4070/kcj.2023.0245
- Open Access
- 1 January 2006
- Published by Radcliffe Medical Media Ltd in European Cardiology Review
- No. 2,p. 14
Cerebrovascular Protection by New Antihyper tensive Drugs – Focus on RAS Blocking Agents in Stroke Prevention
Cerebrovascular accidents are one of the leading causes of morbidity and mortality worldwide. The World Health Organization (WHO) found that in 1990 stroke accounted for 4.3 million mortalities, the third most common cause of death worldwide. Projecting forward to 2020, the incidence of stroke-related death is expected to rise to 7.7 million per year.
- 1 January 2006
- Published by Radcliffe Medical Media Ltd in European Cardiology Review
- No. 2,p. 14
Open AccessCerebrovascular Protection by New Antihyper tensive Drugs – Focus on RAS Blocking Agents in Stroke Prevention
Cerebrovascular accidents are one of the leading causes of morbidity and mortality worldwide. The World Health Organization (WHO) found that in 1990 stroke accounted for 4.3 million mortalities, the third most common cause of death worldwide. Projecting forward to 2020, the incidence of stroke-related death is expected to rise to 7.7 million per year.